Animal studies have demonstrated BPC-157's potential for accelerating the healing of muscles, tendons, and ligaments, reducing inflammation throughout the body, supporting gut and gastrointestinal healing, providing neuroprotective and neuro-regenerative effects, and promoting the growth of new blood vessels (angiogenesis)
3 Individuals must demonstrate deficiency in the diagnostic blood test to qualify for treatment but types of blood tests and cut-off rates vary
Anaphylactic shock and death have been reported
If the PCAC issues favorable recommendations and the FDA subsequently reclassifies any of these peptides into Category 1, the availability of pharmaceutical-grade API will likely become the principal bottleneck governing how quickly compounding pharmacies can bring compliant products to market
Peak BAC is highest for any given dose
Dose ranges below come from individual-compound research and community protocol structure